United States Biotechnology & Medical Research

InterMune Inc (ITMN)

Track

Stock chart
Ticker: ITMN Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Powell Andrew Kenneth William
EVP, GC & Secretary
1 sale — total 551,035 USD
Planned sale 2 Sep 2014
Value US$2,850,541.71 | Price 391.01 | Shares 92,862
Planned sale 15 Aug 2014
Value US$546,908.18 | Price 17.84 | Shares 67,945
Planned sale 13 Aug 2014
Value US$375,000.00 | Price 50.00 | Shares 7,500
Planned sale 13 Aug 2014
Value US$850,000.00 | Price 50.00 | Shares 17,000
Planned sale 7 Aug 2014
Value US$1,124,812.68 | Price 45.17 | Shares 24,900
Planned sale 5 Aug 2014
Value US$6,568,684.06 | Price 44.95 | Shares 146,125
Planned sale 15 Jul 2014
Value US$1,507,709.00 | Price 43.08 | Shares 35,000
Planned sale 18 Jun 2014
Value US$471,000.00 | Price 47.10 | Shares 10,000
Planned sale 16 Jun 2014
Value US$675,252.00 | Price 45.02 | Shares 15,000
Planned sale 13 Jun 2014
Value US$443,500.00 | Price 44.35 | Shares 10,000
Planned sale 6 Jun 2014
Value US$412,500.00 | Price 41.25 | Shares 10,000
Sale 4 Jun 2014
Value US$480,902.03 | Price 39.79 | Shares 12,085
Sale 30 May 2014
Value US$19,661.80 | Price 39.32 | Shares 500
Sale 29 May 2014
Value US$19,780.00 | Price 39.56 | Shares 500
Sale 29 May 2014
Value US$197,800.00 | Price 39.56 | Shares 5,000
Planned sale 27 May 2014
Value US$278,969.69 | Price 40.15 | Shares 6,949
Planned sale 23 May 2014
Value US$400,000.00 | Price 40.00 | Shares 10,000
Planned sale 23 May 2014
Value US$1,381,974.17 | Price 40.01 | Shares 34,544
Planned sale 19 May 2014
Value US$441,066.00 | Price 38.00 | Shares 11,607
Planned sale 6 May 2014
Value US$1,135,011.80 | Price 36.01 | Shares 31,519
Planned sale 5 May 2014
Value US$965,370.37 | Price 33.39 | Shares 28,913
Planned sale 4 Mar 2014
Value US$630,286.00 | Price 31.51 | Shares 20,000
Sale 4 Mar 2014
Value US$2,158,695.00 | Price 30.84 | Shares 70,000
Planned sale 25 Feb 2014
Value US$2,610,009.70 | Price 35.69 | Shares 73,130
Planned sale 25 Feb 2014
Value US$3,082,009.95 | Price 35.69 | Shares 86,355
Planned sale 25 Feb 2014
Value US$1,340,767.42 | Price 32.63 | Shares 41,087
Planned sale 1 Oct 2013
Value US$1,080,016.00 | Price 15.43 | Shares 70,000
Sale 30 Aug 2013
Value US$148,244.64 | Price 14.82 | Shares 10,002
Buy 27 Aug 2013
Value US$71,129.52 | Price 14.37 | Shares 4,950
Buy 26 Aug 2013
Value US$24,743.07 | Price 15.00 | Shares 1,650
Planned sale 27 Jul 2011
Value US$63,286.02 | Price 35.16 | Shares 1,800
Planned sale 20 Jul 2011
Value US$264,242.09 | Price 36.25 | Shares 7,290
Planned sale 20 Jul 2011
Value US$262,694.32 | Price 36.23 | Shares 7,250
Planned sale 13 Jul 2011
Value US$215,847.60 | Price 35.97 | Shares 6,000
Planned sale 6 Jul 2011
Value US$259,837.82 | Price 35.84 | Shares 7,250
Planned sale 6 Jul 2011
Value US$261,117.59 | Price 35.82 | Shares 7,290
Planned sale 29 Jun 2011
Value US$212,836.20 | Price 35.47 | Shares 6,000
Planned sale 22 Jun 2011
Value US$233,462.25 | Price 32.03 | Shares 7,290
Planned sale 22 Jun 2011
Value US$253,908.78 | Price 35.02 | Shares 7,250
Planned sale 21 Jun 2011
Value US$255,150.00 | Price 35.00 | Shares 7,290
Planned sale 21 Jun 2011
Value US$253,750.00 | Price 35.00 | Shares 7,250
Planned sale 21 Jun 2011
Value US$210,000.00 | Price 35.00 | Shares 6,000
Sale 20 Jun 2011
Value US$209,188.23 | Price 33.22 | Shares 6,297
Sale 20 Jun 2011
Value US$791,986.65 | Price 33.15 | Shares 23,891
Sale 20 Jun 2011
Value US$248,914.00 | Price 34.00 | Shares 7,321
Sale 20 Jun 2011
Value US$248,914.00 | Price 34.00 | Shares 7,321
Sale 17 Jun 2011
Value US$1,307,995.38 | Price 33.78 | Shares 38,721
Sale 14 Jun 2011
Value US$688,017.00 | Price 33.00 | Shares 20,849
Sale 14 Jun 2011
Value US$700,029.00 | Price 33.00 | Shares 21,213
Sale 8 Jun 2011
Value US$316,074.00 | Price 33.00 | Shares 9,578
Sale 8 Jun 2011
Value US$691,123.23 | Price 32.64 | Shares 21,176
Sale 2 Jun 2011
Value US$72,819.00 | Price 36.41 | Shares 2,000
Planned sale 1 Jun 2011
Value US$220,724.40 | Price 36.79 | Shares 6,000
Sale 1 Jun 2011
Value US$119,379.42 | Price 37.01 | Shares 3,226
Sale 1 Jun 2011
Value US$116,301.43 | Price 36.50 | Shares 3,186
Sale 31 May 2011
Value US$1,344,761.53 | Price 37.16 | Shares 36,189
Sale 18 May 2011
Value US$4,252,602.23 | Price 38.78 | Shares 109,656
Planned sale 18 May 2011
Value US$223,018.20 | Price 37.17 | Shares 6,000
Planned sale 18 May 2011
Value US$67,094.83 | Price 37.05 | Shares 1,811
Planned sale 18 May 2011
Value US$67,821.76 | Price 37.22 | Shares 1,822
Planned sale 18 May 2011
Value US$772,323.30 | Price 37.22 | Shares 20,750
Sale 17 May 2011
Value US$1,507,817.07 | Price 37.75 | Shares 39,939
Planned sale 16 May 2011
Value US$133,961.10 | Price 38.22 | Shares 3,505
Sale 16 May 2011
Value US$36,193.24 | Price 37.78 | Shares 958
Sale 13 May 2011
Value US$76,425.01 | Price 39.85 | Shares 1,918
Planned sale 12 May 2011
Value US$7,250,315.08 | Price 38.59 | Shares 187,887
Sale 12 May 2011
Value US$5,729,080.00 | Price 40.00 | Shares 143,227
Sale 12 May 2011
Value US$5,271,732.15 | Price 40.14 | Shares 131,332
Sale 12 May 2011
Value US$4,499,117.93 | Price 38.84 | Shares 115,842
Sale 12 May 2011
Value US$3,434,255.83 | Price 38.89 | Shares 88,311
Sale 12 May 2011
Value US$2,795,228.81 | Price 39.13 | Shares 71,443
Planned sale 4 May 2011
Value US$242,164.45 | Price 44.03 | Shares 5,500
Planned sale 4 May 2011
Value US$264,564.60 | Price 44.09 | Shares 6,000
Planned sale 4 May 2011
Value US$248,816.36 | Price 44.03 | Shares 5,651
Planned sale 20 Apr 2011
Value US$278,605.80 | Price 46.43 | Shares 6,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2014-09-03 2014-09-02 PlS Planned sale Powell Andrew Kenneth William

EVP, GC & Secretary

Officer
92,862 +28.0%
391.01
US$2,850,542 		92,862 +28.0% 391.01 US$2,850,542
2014-08-20 2014-08-15 PlS Planned sale Di Nepi Giacomo

EVP Managing Director, Europe

Officer
67,945 +8.4%
17.84
US$546,908 		67,945 +8.4% 17.84 US$546,908
2014-08-14 2014-08-13 PlS Planned sale ARATA PAUL D

EVP, Human Resources & Admin

Officer
58,557 +3.1%
430.86
US$3,175,234 		58,557 +3.1% 430.86 US$3,175,234
2014-08-14 2014-08-13 PlS Planned sale Nolan Sean P.

EVP & CBO

Officer
17,000 -20.6%
50.00
US$850,000 		17,000 -20.6% 50.00 US$850,000
2014-08-07 2014-08-07 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
24,900 -20.9%
45.17
US$1,124,813 		24,900 -20.9% 45.17 US$1,124,813
2014-08-07 2014-08-05 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
146,125 -60.8%
44.95
US$6,568,684 		146,125 -60.8% 44.95 US$6,568,684
2014-07-17 2014-07-15 PlS Planned sale Leff Jonathan A

EVP, Research & Development

Officer
35,000 -43.1%
43.08
US$1,507,709 		35,000 -43.1% 43.08 US$1,507,709
2014-06-20 2014-06-18 PlS Planned sale Nolan Sean P.

EVP & CBO

Officer
10,000 -13.2%
47.10
US$471,000 		10,000 -13.2% 47.10 US$471,000
2014-06-18 2014-06-16 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
15,000 -13.7%
45.02
US$675,252 		15,000 -13.7% 45.02 US$675,252
2014-06-13 2014-06-13 PlS Planned sale Nolan Sean P.

EVP & CBO

Officer
10,000 -13.2%
44.35
US$443,500 		10,000 -13.2% 44.35 US$443,500
2014-06-13 2014-06-06 PlS Planned sale Nolan Sean P.

EVP & CBO

Officer
10,000 -13.2%
41.25
US$412,500 		10,000 -13.2% 41.25 US$412,500
2014-08-20 2014-06-04 S Sale Di Nepi Giacomo

EVP Managing Director, Europe

Officer
12,085 -29.7%
39.79
US$480,902 		12,085 -29.7% 39.79 US$480,902
2014-06-03 2014-05-30 S Sale Powell Andrew Kenneth William

EVP, GC & Secretary

Officer
500 -1.6%
39.32
US$19,662 		500 -1.6% 39.32 US$19,662
2014-06-03 2014-05-29 S Sale Powell Andrew Kenneth William

EVP, GC & Secretary

Officer
500 -1.6%
39.56
US$19,780 		500 -1.6% 39.56 US$19,780
2014-06-02 2014-05-29 S Sale KABAKOFF DAVID S Non-Executive Director
5,000 -18.8%
39.56
US$197,800 		5,000 -18.8% 39.56 US$197,800
2014-05-28 2014-05-27 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
6,949 -6.9%
40.15
US$278,970 		6,949 -6.9% 40.15 US$278,970
2014-06-04 2014-05-23 PlS Planned sale ARATA PAUL D

EVP, Human Resources & Admin

Officer
10,000 -30.5%
40.00
US$400,000 		10,000 -30.5% 40.00 US$400,000
2014-05-28 2014-05-23 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
34,544 -26.9%
40.01
US$1,381,974 		34,544 -26.9% 40.01 US$1,381,974
2014-05-21 2014-05-19 PlS Planned sale WELCH DANIEL G

Charman, CEO and President

Executive Director
11,607 -11.0%
38.00
US$441,066 		11,607 -11.0% 38.00 US$441,066
2014-05-07 2014-05-06 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
31,519 -24.3%
36.01
US$1,135,012 		31,519 -24.3% 36.01 US$1,135,012
2014-05-07 2014-05-05 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
28,913 -22.8%
33.39
US$965,370 		28,913 -22.8% 33.39 US$965,370
2014-03-05 2014-03-04 PlS Planned sale Leff Jonathan A

EVP of R&D

Officer
20,000 -30.0%
31.51
US$630,286 		20,000 -30.0% 31.51 US$630,286
2014-03-05 2014-03-04 S Sale Di Nepi Giacomo

EVP, Managing Director, Europe

Officer
70,000 -72.6%
30.84
US$2,158,695 		70,000 -72.6% 30.84 US$2,158,695
2014-02-27 2014-02-25 PlS Planned sale HODGMAN JOHN

EVP-Finance & CFO

Officer
73,130 -73.6%
35.69
US$2,610,010 		73,130 -73.6% 35.69 US$2,610,010
2014-02-27 2014-02-25 PlS Planned sale HODGMAN JOHN

EVP-Finance & CFO

Officer
86,355 -46.5%
35.69
US$3,082,010 		86,355 -46.5% 35.69 US$3,082,010
2014-02-27 2014-02-25 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
41,087 -23.0%
32.63
US$1,340,767 		41,087 -23.0% 32.63 US$1,340,767
2013-10-03 2013-10-01 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
70,000 -30.8%
15.43
US$1,080,016 		70,000 -30.8% 15.43 US$1,080,016
2013-09-04 2013-08-30 S Sale KABAKOFF DAVID S
10,002 -24.7%
14.82
US$148,245 		10,002 -24.7% 14.82 US$148,245
2013-08-28 2013-08-27 B Purchase Russell Angus C. Non-Executive Director
4,950 +53.8%
14.37
US$71,130 		4,950 +53.8% 14.37 US$71,130
2013-08-28 2013-08-26 B Purchase Russell Angus C. Non-Executive Director
1,650 +21.8%
15.00
US$24,743 		1,650 +21.8% 15.00 US$24,743
2011-07-27 2011-07-27 PlS Planned sale Bradford Williamson Z III

SVP-Clinical Science

Officer
1,800 -2.8%
35.16
US$63,286 		1,800 -2.8% 35.16 US$63,286
2011-07-21 2011-07-20 PlS Planned sale Porter Steven Bryant

Chief Medical Officer

Officer
7,290 -14.1%
36.25
US$264,242 		7,290 -14.1% 36.25 US$264,242
2011-07-21 2011-07-20 PlS Planned sale ARMSTRONG MARIANNE

SVP Ch Reg & Drug Safety Off

Officer
7,250 -14.0%
36.23
US$262,694 		7,250 -14.0% 36.23 US$262,694
2011-07-14 2011-07-13 PlS Planned sale Bradford Williamson Z III

SVP-Clinical Science

Officer
6,000 -8.9%
35.97
US$215,848 		6,000 -8.9% 35.97 US$215,848
2011-07-07 2011-07-06 PlS Planned sale ARMSTRONG MARIANNE

SVP Ch Reg & Drug Safety Off

Officer
7,250 -14.0%
35.84
US$259,838 		7,250 -14.0% 35.84 US$259,838
2011-07-07 2011-07-06 PlS Planned sale Porter Steven Bryant

Chief Medical Officer

Officer
7,290 -14.1%
35.82
US$261,118 		7,290 -14.1% 35.82 US$261,118
2011-06-30 2011-06-29 PlS Planned sale Bradford Williamson Z III

SVP-Clinical Science

Officer
6,000 -8.9%
35.47
US$212,836 		6,000 -8.9% 35.47 US$212,836
2011-06-23 2011-06-22 PlS Planned sale Porter Steven Bryant

Chief Medical Officer

Officer
7,290 -14.1%
32.03
US$233,462 		7,290 -14.1% 32.03 US$233,462
2011-06-23 2011-06-22 PlS Planned sale ARMSTRONG MARIANNE

SVP Ch Reg & Drug Safety Off

Officer
7,250 -14.0%
35.02
US$253,909 		7,250 -14.0% 35.02 US$253,909
2011-06-23 2011-06-21 PlS Planned sale Porter Steven Bryant

Chief Medical Officer

Officer
7,290 -14.1%
35.00
US$255,150 		7,290 -14.1% 35.00 US$255,150
2011-06-23 2011-06-21 PlS Planned sale ARMSTRONG MARIANNE

SVP Ch Reg & Drug Safety Off

Officer
7,250 -14.0%
35.00
US$253,750 		7,250 -14.0% 35.00 US$253,750
2011-06-23 2011-06-21 PlS Planned sale Bradford Williamson Z III

SVP-Clinical Science

Officer
6,000 -8.9%
35.00
US$210,000 		6,000 -8.9% 35.00 US$210,000
2011-06-22 2011-06-20 S Sale Seiwert Scott

SVP, Rsearch & Technical Dev.

Officer
6,297 -14.0%
33.22
US$209,188 		6,297 -14.0% 33.22 US$209,188
2011-06-22 2011-06-20 S Sale Seiwert Scott

SVP, Rsearch & Technical Dev.

Officer
23,891 -34.6%
33.15
US$791,987 		23,891 -34.6% 33.15 US$791,987
2011-06-22 2011-06-20 S Sale Porter Steven Bryant

Chief Medical Officer

Officer
7,321 -14.1%
34.00
US$248,914 		7,321 -14.1% 34.00 US$248,914
2011-06-22 2011-06-20 S Sale ARMSTRONG MARIANNE

SVP Ch Reg & Drug Safety Off

Officer
7,321 -14.1%
34.00
US$248,914 		7,321 -14.1% 34.00 US$248,914
2011-06-21 2011-06-17 S Sale Steele Robin Joan

SVP, GC, Secretary

Officer
38,721 -71.4%
33.78
US$1,307,995 		38,721 -71.4% 33.78 US$1,307,995
2011-06-15 2011-06-14 S Sale Cohen Alan Howard

SVP, Medical Affairs

Officer
20,849 -50.6%
33.00
US$688,017 		20,849 -50.6% 33.00 US$688,017
2011-06-15 2011-06-14 S Sale Simon Howard Allan

SVP-Human Resources

Officer
21,213 -46.8%
33.00
US$700,029 		21,213 -46.8% 33.00 US$700,029
2011-06-10 2011-06-08 S Sale Simon Howard Allan

SVP-Human Resources

Officer
9,578 -23.7%
33.00
US$316,074 		9,578 -23.7% 33.00 US$316,074
2011-06-10 2011-06-08 S Sale Simon Howard Allan

SVP-Human Resources

Officer
21,176 -34.4%
32.64
US$691,123 		21,176 -34.4% 32.64 US$691,123
2011-06-03 2011-06-02 S Sale KABAKOFF DAVID S Non-Executive Director
2,000 -3.8%
36.41
US$72,819 		2,000 -3.8% 36.41 US$72,819
2011-06-02 2011-06-01 PlS Planned sale Bradford Williamson Z III

SVP-Clinical Science

Officer
6,000 -8.3%
36.79
US$220,724 		6,000 -8.3% 36.79 US$220,724
2011-06-02 2011-06-01 S Sale Porter Steven Bryant

Chief Medical Officer

Officer
3,226 -5.4%
37.01
US$119,379 		3,226 -5.4% 37.01 US$119,379
2011-06-02 2011-06-01 S Sale ARMSTRONG MARIANNE

SVP Ch Reg & Drug Safety Off

Officer
3,186 -5.4%
36.50
US$116,301 		3,186 -5.4% 36.50 US$116,301
2011-06-01 2011-05-31 S Sale Cohen Alan Howard

SVP, Medical Affairs

Officer
36,189 -57.3%
37.16
US$1,344,762 		36,189 -57.3% 37.16 US$1,344,762
2011-05-20 2011-05-18 S Sale Simon Howard Allan

SVP-Human Resources

Officer
109,656 -73.1%
38.78
US$4,252,602 		109,656 -73.1% 38.78 US$4,252,602
2011-05-19 2011-05-18 PlS Planned sale Bradford Williamson Z III

SVP-Clinical Science

Officer
6,000 -8.3%
37.17
US$223,018 		6,000 -8.3% 37.17 US$223,018
2011-05-19 2011-05-18 PlS Planned sale Porter Steven Bryant

Chief Medical Officer

Officer
1,811 -3.0%
37.05
US$67,095 		1,811 -3.0% 37.05 US$67,095
2011-05-19 2011-05-18 PlS Planned sale ARMSTRONG MARIANNE

SVP Ch Reg & Drug Safety Off

Officer
1,822 -3.0%
37.22
US$67,822 		1,822 -3.0% 37.22 US$67,822
2011-05-18 2011-05-18 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
20,750 -7.4%
37.22
US$772,323 		20,750 -7.4% 37.22 US$772,323
2011-05-18 2011-05-17 S Sale Di Nepi Giacomo

SVP, Managing Director, Europe

Officer
39,939 -61.9%
37.75
US$1,507,817 		39,939 -61.9% 37.75 US$1,507,817
2011-05-18 2011-05-16 PlS Planned sale WELCH DANIEL G

Chairman, CEO and President

Executive Director
3,505 -1.2%
38.22
US$133,961 		3,505 -1.2% 38.22 US$133,961
2011-05-18 2011-05-16 S Sale Bradford Williamson Z III

SVP-Clinical Science

Officer
958 -1.4%
37.78
US$36,193 		958 -1.4% 37.78 US$36,193
2011-05-16 2011-05-13 S Sale Bradford Williamson Z III

SVP-Clinical Science

Officer
1,918 -2.8%
39.85
US$76,425 		1,918 -2.8% 39.85 US$76,425
2011-05-16 2011-05-12 PlS Planned sale Steele Robin Joan

SVP, GC, Secretary

Officer
187,887 -75.3%
38.59
US$7,250,315 		187,887 -75.3% 38.59 US$7,250,315
2011-05-16 2011-05-12 S Sale HODGMAN JOHN

SVP-Finance & CFO

Officer
143,227 -86.7%
40.00
US$5,729,080 		143,227 -86.7% 40.00 US$5,729,080
2011-05-16 2011-05-12 S Sale ARMSTRONG MARIANNE

SVP Ch Reg & Drug Safety Off

Officer
131,332 -69.2%
40.14
US$5,271,732 		131,332 -69.2% 40.14 US$5,271,732
2011-05-16 2011-05-12 S Sale Bradford Williamson Z III

SVP-Clinical Science

Officer
115,842 -63.2%
38.84
US$4,499,118 		115,842 -63.2% 38.84 US$4,499,118
2011-05-16 2011-05-12 S Sale Porter Steven Bryant

Chief Medical Officer

Officer
88,311 -60.1%
38.89
US$3,434,256 		88,311 -60.1% 38.89 US$3,434,256
2011-05-16 2011-05-12 S Sale Seiwert Scott

SVP, Rsearch & Technical Dev.

Officer
71,443 -60.3%
39.13
US$2,795,229 		71,443 -60.3% 39.13 US$2,795,229
2011-05-05 2011-05-04 PlS Planned sale Porter Steven Bryant

Chief Medical Officer

Officer
5,500 -8.7%
44.03
US$242,164 		5,500 -8.7% 44.03 US$242,164
2011-05-05 2011-05-04 PlS Planned sale Bradford Williamson Z III

SVP-Clinical Science

Officer
6,000 -8.3%
44.09
US$264,565 		6,000 -8.3% 44.09 US$264,565
2011-05-05 2011-05-04 PlS Planned sale ARMSTRONG MARIANNE

SVP Ch Reg & Drug Safety Off

Officer
5,651 -8.9%
44.03
US$248,816 		5,651 -8.9% 44.03 US$248,816
2011-04-21 2011-04-20 PlS Planned sale Bradford Williamson Z III

SVP-Clinical Science

Officer
6,000 -8.3%
46.43
US$278,606 		6,000 -8.3% 46.43 US$278,606
Explore more

More insider trading research around InterMune Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America